Overexpression of Urinary N-Domain ACE in Chronic Kidney Dysfunction in Wistar Rats

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Clinical and experimental hypertension

• Publication date

  2012-09-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/10641963.2011.649932PMID 22468863
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biomarkers of Acute and Chronic Kidney Disease.

  2019cited by this paper
• Urinary proteomics and drug discovery in chronic kidney disease: a new perspective.

  2011cited by this paper
• Review: Serum and urine biomarkers of kidney disease: A pathophysiological perspective

  2010cited by this paper
• The use of targeted biomarkers for chronic kidney disease.

  2010cited by this paper
• Novel biomarkers for progression of chronic kidney disease.

  2010cited by this paper
• Role of the Intrarenal Renin-Angiotensin-Aldosterone System in Chronic Kidney Disease

  2010cited by this paper
• Proteomics database in chronic kidney disease.

  2010cited by this paper
• Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with chronic kidney disease.

  2010cited by this paper
• The Emerging Role of Biomarkers in Diabetic and Hypertensive Chronic Kidney Disease

  2010cited by this paper
• Targeting the renin angiotensin system for remission/regression of chronic kidney disease.

  2010cited by this paper
• Application of Direct Renin Inhibition to Chronic Kidney Disease

  2010cited by this paper
• ACE Activity Is Modulated by Kinin B2 Receptor

  2008cited by this paper
• Expression of angiotensin I-converting enzymes and bradykinin B2 receptors in mouse inner medullary-collecting duct cells.

  2008cited by this paper
• Intra-Renal Angiotensin II/AT1 Receptor, Oxidative Stress, Inflammation, and Progressive Injury in Renal Mass Reduction

  2007cited by this paper
• Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation.

  2006cited by this paper
• Angiotensin II production and distribution in the kidney: I. A kinetic model.

  2006cited by this paper
• N-domain angiotensin-converting enzyme isoform expression in tissues of Wistar and spontaneously hypertensive rats

  2005cited by this paper
• Localization of an N-domain region of angiotensin-converting enzyme involved in the regulation of ectodomain shedding using monoclonal antibodies.

  2005cited by this paper
• Intrarenal Renin-Angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis.

  2004cited by this paper
• N-Domain Angiotensin I-Converting Enzyme With 80 kDa as a Possible Genetic Marker of Hypertension

  2003cited by this paper
• Ultrastructural changes in the remnant kidney (after 5/6 nephrectomy) glomerulus after losartan and atenolol treatment.

  2003cited by this paper
• Differing anti-proteinuric action of candesartan and losartan in chronic renal disease.

  2003cited by this paper
• Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury.

  2002cited by this paper
• Chronic Angiotensin-Converting Enzyme Inhibition and Angiotensin II Antagonism in Rats With Chronic Renal Failure

  2002cited by this paper
• Materials and Methods Protocol 1 : Assessment of AT 1 and AT 2 Receptor Expression in the Remnant Kidney

  2002cited by this paper
• The renin-angiotensin system and the exocrine pancreas.

  2001cited by this paper
• Enhancement of Angiotensinogen Expression in Angiotensin II-Dependent Hypertension

  2001cited by this paper
• Angiotensin converting enzymes from human urine of mild hypertensive untreated patients resemble the N-terminal fragment of human angiotensin I-converting enzyme.

  2001cited by this paper
• Angiotensin-(1-7) potentiates the coronary vasodilatatory effect of bradykinin in the isolated rat heart.

  2000cited by this paper
• Angiotensin induces inflammatory activation of human vascular smooth muscle cells.

  1999cited by this paper
• Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation.

  1999cited by this paper
• Purification and characterization of angiotensin I‐converting enzymes from mesangial cells in culture

  1998cited by this paper
• Experimental Focal Segmental Glomerulosclerosis in Mice

  1998cited by this paper
• Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation.

  1998cited by this paper
• Angiotensin II induces vascular smooth muscle cell replication independent of blood pressure.

  1998cited by this paper
• Alternative splicing of the mRNA coding for the human endothelial angiotensin-converting enzyme: a new mechanism for solubilization.

  1998cited by this paper
• The Hemoregulatory Peptide N-Acetyl-Ser-Asp-Lys-Pro Is a Natural and Specific Substrate of the N-terminal Active Site of Human Angiotensin-converting Enzyme (*)

  1995cited by this paper
• Opposing actions of angiotensin-(1-7) and angiotensin II in the brain of transgenic hypertensive rats.

  1995cited by this paper
• Naturally occurring active N-domain of human angiotensin I-converting enzyme.

  1994cited by this paper
• Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides.

  1993cited by this paper
• In Vivo Metabolism of Angiotensin I by Neutral Endopeptidase (EC 3.4.24.11) in Spontaneously Hypertensive Rats

  1992cited by this paper
• The two homologous domains of human angiotensin I-converting enzyme are both catalytically active.

  1991cited by this paper
• The testicular transcript of the angiotensin I‐converting enzyme encodes for the ancestral, non‐duplicated form of the enzyme

  1989cited by this paper
• Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning.

  1988cited by this paper
• Circulating and Tissue Angiotensin Systems

  1987cited by this paper
• Circulating and tissue angiotensin systems.

  1987cited by this paper
• Angiotensin-converting enzyme in epithelial and neuroepithelial cells.

  1983cited by this paper
• Isolation and characterization of angiotensin converting enzyme from human kidney.

  1981cited by this paper
• Angiotensin I-converting enzyme in human urine.

  1978cited by this paper
• A sensitive fluorimetric assay for serum angiotensin-converting enzyme.

  1976cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Concentrations of angiotensin-converting enzyme in tissues of the rat.

  1971cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Kidney Volume as a Predictor and Modifier of Acute Kidney Injury with Renin-Angiotensin System Inhibitors.

  2025cites this paper
• Association of Ang-(1–7) and des-Arg9BK as new biomarkers of obesity and cardiometabolic risk factors in adolescents

  2021cites this paper
• The effects of angiotensin-(1-7) on the exchanger NHE3 and on [Ca2+]i in the proximal tubules of spontaneously hypertensive rats.

  2017cites this paper
• Insulin treatment attenuates renal ADAM17 and ACE2 shedding in diabetic Akita mice.

  2014cites this paper
• PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS DA REABILITAÇÃO

  2014cites this paper
• Rosiglitazone Treatment of Type 2 Diabetic db/db Mice Attenuates Urinary Albumin and Angiotensin Converting Enzyme 2 Excretion

  2013cites this paper